Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...

Researchers at ETH Zurich have used a drug screening platform they developed to show that an antidepressant, currently on the ...

Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to forthcoming clinical trials. Glioblastoma is an incurable and fatal type of brain ...

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumor cell growth, HER2. Despite this common trait, the development of ...

A nationwide clinical trial shows positive results for cancer patients with this common wasting syndrome. Researchers discovered a drug that safely and effectively helped cancer patients when they ...

A biotech that uses artificial intelligence to assist its drug discovery efforts has relocated its headquarters from New York ...

Earlier this week, we took a look at Argenica Therapeutics (ASX:AGN), a brain injury-focused clinical-stage biotech ...

As Enhertu’s reach continues to spread into additional forms of breast cancer, Daiichi Sankyo and AstraZeneca are ramping up ...

Truelove and Witts published the first placebo-controlled, randomised clinical trial in inflammatory bowel disease (IBD), which showed the superiority of cortisone for the treatment of acute ...

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

Health tech startup Dandelion Health launched a clinical artificial intelligence marketplace that merges third-party ...

Shares of biopharma outfit Edgewise Therapeutics (NASDAQ: EWTX) soared more than 50% today, reaching a three-year high following an update on the clinical testing of its cardiac drug EDG-7500. The ...